Glyxambi recalls
Glyxambi products have been recalled 1 time, most recently on 2 Jun 2021. The recalling company is usually Cardinal Health. The most common reason is manufacturing (cgmp) deviations.
Total recalls1since 2021
Last 12 months0reported
Class I00% of total
Ongoing0latest 2 Jun 2021
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why glyxambi is recalled
Companies
Product types
By year
All glyxambi recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Glyxambi (empagliflozin and linagliptin) Tablets 25 mg/5 mg recalledGlyxambi | Cardinal Health | Manufacturing (CGMP) Deviations | FL, GA, SC |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.